Search Results - abraham+sonenshein
3 Results
Sort By:
-
Inhibitors of Clostridium difficile spore germination and outgrowth
Inhibitors of Clostridium difficile spore germinationTufts case T001523Technology• Spore formation by Clostridium difficile is a significant obstacle to overcoming hospital-acquired C. difficile-associated disease (CDAD). Spores are resistant to heat, radiation, chemicals, and antibiotics, making a contaminated environment difficult to clean....
Published: 3/19/2021
Inventor(s): Abraham Sonenshein, Joseph Sorg
Keywords(s):
Category(s): Diseases: infectious, Screening: target, Therapeutic: antibiotic, Therapeutic: small molecule
-
Spore Vaccine for Rotavirus
Heat-stable, injection-free vaccine platformThe invention is a novel vaccine platform utilizing the non-pathogenic bacterium Bacillus subtilis as the antigen-producer. A desired antigen can be engineered to be under the control of a pro-vegetative state or a pro-sporulation promoter. Cells are induced to express the desired antigen on the cell surface...
Published: 7/30/2021
Inventor(s): John Herrmann, Abraham Sonenshein, Saul Tzipori, Boris Belitsky
Keywords(s):
Category(s): Therapeutic: vaccine
-
Research Tool: Stable reporter system for promoter activity in Listeria monocytogenes
Stable reporter system for promoter activity in Listeria monocytogenes
Published: 4/2/2020
Inventor(s): Abraham Sonenshein, Hyun-Jin Kim
Keywords(s):
Category(s): Research tool: expression system